UCL Proton Therapy Research Group

PART - Proton and Advanced Radiotherapy

People Publications Projects Grants

The treatment of complex cancers requires an evolution in the technology, techniques and software to increase survival rates and to personalise the patient’s therapy. Our research aims to bring new developments in a wide range of disciplines, such as physics, engineering, computer science, imaging science, biology, nanotechnology and oncology, to the field of conformal radiotherapy. 

About us

PART is a multi-disciplinary, cross-faculty research network featuring physicists, computer scientists, engineers, biologists, oncologists and radiographers based across UCL and UCLH. This involves academics, postdoctoral researchers, PhD and MSc students from the UCL faculties of Engineering, Life Sciences, Medical Sciences and Maths and Physical Sciences, and clinical physicists, radiographers and radiation oncologists from UCLH Radiotherapy.

Research Fundraising

Prostate Cancer RADAR : RADiotherapy Advances and Research: The aim is to research and develop new technologies in radiotherapy to treat prostate cancer with the aims of increasing cure rates and reducing side effects. For more information or to donate to this research fund please visit the JustGiving page.

Proton therapy at UCLH

Green light for two proton beam therapy centres. The building of two state-of-art proton beam therapy cancer treatment centres at University College London Hospitals NHS Foundation Trust and the Christie NHS Foundation Trust in Manchester will start this summer. Varian Medical Systems has been named as the equipment supplier for both, with Bouygues UK as the building contractor for UCLH and Interserve Construction Ltd at the Christie.
The government has invested £250 million in the facilities to give NHS patients a highly-targeted type of radiotherapy that can treat hard-to-reach cancers without causing damage to surrounding tissue or other side effects. The centres are expected to open for patients in 2018.

Proton beam therapy centres

  • The advantage of proton beam therapy over conventional radiotherapy lies within the precision of the proton beam, which results in higher doses of radiotherapy being delivered. By precisely targeting the cancer, normal tissues receive very little radiation, leading to fewer side-effects and reduced long term consequences, including the risk of a secondary malignancy - this is particularly important for children.
  • An NHS internal competition was held to identify appropriate centres capable of meeting the commissioner’s requirements to deliver a UK-based proton beam therapy service. University College London Hospitals NHS Foundation Trusts and the Christie NHS Foundation Trust (Manchester) were chosen.
  • Since 2008, patients who meet the clinical criteria for treatment, are offered NHS funded treatment overseas.

Proton therapy at UCLH

Image: Scott Tallon and Walker, architects

An important focus of our R&D programme is the new UCLH proton therapy centre, due to open in 2018. Many of our projects aim at providing new tools and techniques to support the clinical teams delivering proton treatments.

Further details about proton therapy at UCLH.

Previous events

Monte Carlo user group meeting - April 22, 2015

Further information

If you would like to receive further information about our projects or wish to enquire about joining please contact medphys.part-enquiries@ucl.ac.uk


The Christie NPL MGH
Royal Berkshire Hospital Royal Free Hospital Barts Hospital
UCLH Rutherford Appleton Laboratory IBA